Propel Bio Management, LLC / FDMT
Propel Bio Management, LLC’s 4d Molecular Therapeutics In Position
Does Propel Bio Management, LLC own 4d Molecular Therapeutics In (FDMT)? Yes — 380.4K shares worth $4M (+2.26% of its 13F portfolio) as of Q1 2026.
Position Value
$4M
Q1 2026
Shares
380.4K
% of Portfolio
+2.26%
Quarters Held
1
currently held
Position History FDMT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 380.4K | $4M | +2.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of FDMT.